{"concreteType":"org.sagebionetworks.repo.model.table.QueryResultBundle","queryResult":{"concreteType":"org.sagebionetworks.repo.model.table.QueryResult","queryResults":{"headers":[{"columnType":"ENTITYID","name":"id","id":"2510"},{"columnType":"LARGETEXT","name":"datasetName","id":"70044"},{"columnType":"STRING","name":"diseaseFocus","id":"56918"},{"columnType":"STRING","name":"tumorType","id":"39539"},{"columnType":"LARGETEXT","name":"summary","id":"69194"},{"columnType":"STRING","name":"fundingAgency","id":"38862"},{"columnType":"INTEGER","name":"fileCount","id":"70045"},{"columnType":"INTEGER","name":"fileSize","id":"31167"}],"concreteType":"org.sagebionetworks.repo.model.table.RowSet","tableId":"syn16859580","etag":"d3d03713-6e80-4538-920b-c7c024b6f3a5","rows":[{"values":["syn16812247","Synodos NF2 RNASeq (Processed)","Neurofibromatosis 2","Schwannoma, Meningioma","This set contains counts-level and differential expression data files for NF2 schwannoma and meningioma models that were treated with vehicle control or HDAC, PI3K, and mTOR inhibitors. ","CTF","13","45893643"],"versionNumber":9,"rowId":0},{"values":["syn16815129","Synodos NF2 Drug Screening (Raw and Processed)","Neurofibromatosis 2","Schwannoma, Meningioma","This set contains raw and processed drug screening data for NF2 schwannoma and meningioma models generated that were tested with a panel of 19 experimental therapeutics and drugs.","CTF","3","351612"],"versionNumber":9,"rowId":1},{"values":["syn16815073","pNF Cell Line Single Agent Drug Screening","Neurofibromatosis 1","Plexiform Neurofibroma","This set contains processed high-throughput single-agent drug screening data for pNF cells treated with the NCATS MIPE 4.0 library. ","NTAP","55","3474326"],"versionNumber":9,"rowId":2},{"values":["syn16815072","pNF Cell Line Combination Drug Screening","Neurofibromatosis 1","Plexiform Neurofibroma","This set contains processed high-throughput combination drug screening data for pNF cell lines with compounds from the MIPE 4.0 library. ","NTAP","13","2038281"],"versionNumber":9,"rowId":3}]}},"selectColumns":[{"columnType":"ENTITYID","name":"id","id":"2510"},{"columnType":"LARGETEXT","name":"datasetName","id":"70044"},{"columnType":"STRING","name":"diseaseFocus","id":"56918"},{"columnType":"STRING","name":"tumorType","id":"39539"},{"columnType":"LARGETEXT","name":"summary","id":"69194"},{"columnType":"STRING","name":"fundingAgency","id":"38862"},{"columnType":"INTEGER","name":"fileCount","id":"70045"},{"columnType":"INTEGER","name":"fileSize","id":"31167"}],"columnModels":[{"columnType":"ENTITYID","name":"id","id":"2510"},{"columnType":"LARGETEXT","name":"datasetName","id":"70044"},{"columnType":"STRING","facetType":"enumeration","name":"diseaseFocus","maximumSize":50,"id":"56918"},{"columnType":"STRING","facetType":"enumeration","name":"tumorType","maximumSize":50,"id":"39539"},{"columnType":"LARGETEXT","name":"summary","id":"69194"},{"columnType":"STRING","facetType":"enumeration","name":"fundingAgency","maximumSize":50,"id":"38862"},{"columnType":"INTEGER","name":"fileCount","id":"70045"},{"columnType":"INTEGER","name":"fileSize","id":"31167"}],"facets":[{"facetType":"enumeration","facetValues":[{"count":2,"isSelected":false,"value":"Neurofibromatosis 1"},{"count":2,"isSelected":false,"value":"Neurofibromatosis 2"}],"concreteType":"org.sagebionetworks.repo.model.table.FacetColumnResultValues","columnName":"diseaseFocus"},{"facetType":"enumeration","facetValues":[{"count":2,"isSelected":false,"value":"Plexiform Neurofibroma"},{"count":2,"isSelected":false,"value":"Schwannoma, Meningioma"}],"concreteType":"org.sagebionetworks.repo.model.table.FacetColumnResultValues","columnName":"tumorType"},{"facetType":"enumeration","facetValues":[{"count":2,"isSelected":false,"value":"CTF"},{"count":2,"isSelected":false,"value":"NTAP"}],"concreteType":"org.sagebionetworks.repo.model.table.FacetColumnResultValues","columnName":"fundingAgency"}]}